O/m items only: biological materials, laboratory supplies, chemicals, blood/blood products, media
Active Blanket Purchase Agreement Awarded Last action
- Contract number
- 75N98025A00009
- Awardee
-
Research And Diagnostic Systems, Inc. UEI WAYSQU5HJYT9
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $12,880 obligated
Award facts
- Combined order value
- $12,880 Current and potential, with all options
- Last date to order 99% complete
- IDV ceiling <1% used
- $10,000,000.00
- Maximum order
- $25,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based subsidiary of Bio-Techne Corporation, was awarded a single-award Blanket Purchase Agreement valued at $10.0 million by the Office of Logistics and Acquisition Operations, a civilian federal agency, with an ultimate completion date of October 31, 2026. This non-competitive IDV establishes a framework for the procurement of operations and maintenance items exclusively, including biological materials, laboratory supplies, chemicals, blood products, blood-derived products, and culture media. The agreement specifically authorizes procurement of R&D Systems brand products and Tocris brand chemicals, supporting biomedical research operations across the National Institutes of Health ecosystem. The BPA structure enables flexible task order issuance to accommodate varying research requirements across multiple institutes and centers.
Under this BPA authority, R&D Systems executed a firm fixed-price task order valued at $12,879.50 with the NIH Clinical Center on August 31, 2025, for delivery of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) and recombinant human interferon-gamma (IFN-gamma) as Good Manufacturing Practice grade proteins. This task order, scheduled for completion on September 30, 2025, represents essential biological research materials utilized in immunological and translational science studies. Performance will be conducted at the contractor's Minneapolis, Minnesota facility. The recombinant proteins supplied through this task order support critical federal research initiatives aligned with the NIH Clinical Center's translational and clinical research programs, demonstrating the BPA's operational utility in meeting specialized research material requirements.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Recombinant human GM-CSF GMP protein, CF and recombinant human IFN-gamma GMP protein, CF r & d systems INC:1107462… | NIH Clinical Center | $12,880 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N98025A00009?
75N98025A00009 was awarded to Research And Diagnostic Systems, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on November 1, 2024.
How much is contract 75N98025A00009 worth?
Orders under 75N98025A00009 have obligated $12,880. 75N98025A00009's own ceiling is $10,000,000. A single order can be worth up to $25,000.
How many orders have been placed under contract 75N98025A00009?
1 order has been placed under 75N98025A00009, the latest on August 31, 2025.
Who can order from contract 75N98025A00009?
75N98025A00009 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV